|
1.
Herbert V. Folic Acid. In: Shils M, Olson J, Shike M, Ross AC, ed.
Nutrition in Health and Disease. Baltimore: Williams & Wilkins,
1999.
2.
Kamen B. Folate and antifolate pharmacology. Semin Oncol 1997; 24:S18-30-S18-39.
3.
Fenech M, Aitken C, Rinaldi J. Folate, vitamin B12, homocysteine
status and DNA damage in young Australian adults. Carcinogenesis
1998; 19:1163-71.
4.
Zittoun J. Anemias due to disorder of folate, vitamin B12 and transcobalamin
metabolism. Rev Prat 1993; 43:1358-63.
5.
U.S. Department of Agriculture, Agricultural Research Service,1999.
USDA Nutrient Database for Standard Reference, Release 13. Nutrient
Data Lab Home Page, http://www.nal.usda.gov/fnic/foodcomp
6.
Oakley GP, Jr., Adams MJ, Dickinson CM. More folic acid for everyone,
now. J Nutr 1996; 126:751S-755S.
7.
Malinow MR, Duell PB, Hess DL, Anderson PH, Kruger WD, Phillipson
BE, Gluckman RA, Upson BM. Reduction of plasma homocyst(e)ine levels
by breakfast cereal fortified with folic acid in patients with coronary
heart disease. N Engl J Med 1998; 338:1009-15.
8.
Daly S, Mills JL, Molloy AM, Conley M, Lee YJ, Kirke PN, Weir DG,
Scott JM. Minimum effective dose of folic acid for food fortification
to prevent neural-tube defects. Lancet 1997; 350:1666-9.
9.
Crandall BF, Corson VL, Evans MI, Goldberg JD, Knight G, Salafsky
IS. American College of Medical Genetics statement on folic acid:
Fortification and supplementation. Am J Med Genet 1998; 78:381.
10.
Institute of Medicine. Food and Nutrition Board. Dietary Reference
Intakes: Thiamin, riboflavin, niacin, vitamin B6, folate, vitamin
B12, pantothenic Acid, biotin, and choline. National Academy Press.
Washington, DC, 1998.
11.
Suitor CW and Bailey LB. Dietary folate equivalents: Interpretation
and application. J Am Diet Assoc 2000; 100:88-94.
12.
Raiten DJ and Fisher KD. Assessment of folate methodology used in
the Third National Health and Nutrition Examination Survey (NHANES
III, 1988-1994). J Nutr 1995; 125:1371S-1398S.
13.
Alaimo K, McDowell MA, Briefel RR, Bischlf AM, Caughman CR, Loria
CM, Johnson CL. Dietary Intake of Vitamins, Minerals, and Fiber
of Persons Ages 2 Months and Over in the United States: Third National
Health and Nutrition Examination Survey, Phase 1, 1988-91. In: Johnson
GV, ed. Hyattsville, MD: Vital and Health Statistics of the Center
for Disease Control and Prevention/National Center for Health Statistics,
1994:1-28.
14.
Lewis CJ, Crane NT, Wilson DB, Yetley EA. Estimated folate intakes:
Data updated to reflect food fortification, increased bioavailability,
and dietary supplement use. Am J Clin Nutr 1999; 70:198-207.
15.
McNulty H. Folate requirements for health in different population
groups. Br J Biomed Sci 1995; 52:110-9.
16.
Stolzenberg R. Possible folate deficiency with postsurgical infection.
Nutr Clin Pract 1994;9:247-50.
17.
Cravo ML, Gloria LM, Selhub J, Nadeau MR, Camilo ME, Resende MP,
Cardoso JN, Leitao CN, Mira FC. Hyperhomocysteinemia in chronic
alcoholism: Correlation with folate, vitamin B-12, and vitamin B-6
status. Am J Clin Nutr 1996; 63:220-4.
18.
Pietrzik KF and Thorand B. Folate economy in pregnancy. Nutrition
1997;13:975-7.
19.
Kelly GS. Folates: Supplemental forms and therapeutic applications.
Altern Med Rev 1998; 3:208-20.
20.
Haslam N and Probert CS. An audit of the investigation and treatment
of folic acid deficiency. J R Soc Med 1998; 91:72-3.
21.
Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional
vitamin use, dietary folate, and the occurrence of neural tube defects.
Epidemiology 1995; 6:219-226.
22.
Mulinare J, Cordero JF, Erickson JD, Berry RJ. Periconceptional
use of multivitamins and the occurrence of neural tube defects.
J Am Med Assoc 1988; 260:3141-3145.
23
Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman
KJ, Willett W. Multivitamin/folic acid supplementation in early
pregnancy reduces the prevalence of neural tube defects. J Am Med
Assoc 1989; 262:2847-2852.
24.
Gloria L, Cravo M, Camilo ME, Resende M, Cardoso JN, Oliveira AG,
Leitao CN, Mira FC. Nutritional deficiencies in chronic alcoholics:
Relation to dietary intake and alcohol consumption. Am J Gastroenterol
1997; 92:485-9.
25.
Collins CS, Bailey LB, Hillier S, Cerda JJ, Wilder BJ. Red blood
cell uptake of supplemental folate in patients on anticonvulsant
drug therapy. Am J Clin Nutr 1988; 48:1445-1450.
26.
Young SN and Ghadirian AM. Folic acid and psychopathology. Prog
Neuropsychopharmacol Biol Psychiat 1989; 13:841-863.
27.
Munoz-Garcia D, Del Ser T, Bermejo F, Portera A. Truncal ataxia
in chronic anticonvulsant treatment. Association with drug-induced
folate deficiency. J Neurol Sci 1982; 55:305-11.
28.
Eller DP, Patterson CA, Webb GW. Maternal and fetal implications
of anticonvulsive therapy during pregnancy. Obstet Gynecol Clin
North Am 1997; 24:523-34.
|
29.
Baggott JE, Morgan SL, HaT, Vaughn WH, Hine RJ. Inhibition of folate-dependent
enzymes by non-steroidal anti-inflammatory drugs. Biochem 1992;
282:197-202.
30.
Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger
AJ, O'Leary DH, Wolf PA, Scaefer EJ, Rosenberg IH. Association between
plasma homocysteine concentrations and extracranial carotid-artery
stenosis. N Engl J Med 1995; 332:286-291.
31.
Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE, Hennekens
C, Stampfer MJ. Folate and vitamin B6 from diet and supplements
in relation to risk of coronary heart disease among women. J Am
Med Assoc 1998;279:359-64.
32.
Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular
disease. Annu Rev Med 1998; 49:31-62.
33.
Boers GH. Hyperhomocysteinaemia: A newly recognized risk factor
for vascular disease. Neth J Med 1994; 45:34-41.
34.
Selhub J, Jacque PF, Wilson PF, Rush D, Rosenberg IH. Vitamin status
and intake as primary determinants of homocysteinemia in an elderly
population. J Am Med Assoc 1993 ;270:2693-2698.
35.
Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis.
J Am Coll Cardiol 1996; 27:517-27.
36.
Malinow MR. Plasma homocyst(e)ine and arterial occlusive diseases:
A mini-review. Clin Chem 1995; 41:173-6.
37.
Flynn MA, Herbert V, Nolph GB, Krause G. Atherogenesis and the homocysteine-folate-cobalamin
triad: Do we need standardized analyses? J Am Coll Nutr 1997; 16:258-67.
38.
Fortin LJ and Genest J, Jr. Measurement of homocyst(e)ine in the
prediction of arteriosclerosis. Clin Biochem 1995; 28:155-62.
39.
Siri PW, Verhoef P, Kok FJ. Vitamins B6, B12, and folate: Association
with plasma total homocysteine and risk of coronary atherosclerosis.
J Am Coll Nutr 1998; 17:435-41.
40.
Eskes TK. Open or closed? A world of difference: A history of homocysteine
research. Nutr Rev 1998; 56:236-44.
41.
Ubbink JB, van der Merwe A, Delport R, Allen RH, Stabler SP, Riezler
R, Vermaak WJ. The effect of a subnormal vitamin B-6 status on homocysteine
metabolism. J Clin Invest 1996; 98:177-84.
42.
Freudenheim JL, Grahm S, Marshall JR, Haughey BP, Cholewinski S,
Wilkinson G. Folate intake and carcinogenesis of the colon and rectum.
Int J Epidemiol 1991; 20:368-374.
43.
Jennings E. Folic acid as a cancer preventing agent. Med Hypothesis
1995; 45:297-303.
44.
Christensen B. Folate deficiency, cancer and congenital abnormalities.
Is there a connection? . Tidsskr Nor Laegeforen 1996; 116:250-4.
45.
Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ, Fuchs C, Rosner
BA, Speizer FE, Willett WC. Multivitamin use, folate, and colon
cancer in women in the Nurses' Health Study. Ann Intern Med 1998;
129:517-524.
46.
Rubio IT, Cao Y, Hutchins LF, Westbrook KC, Klimberg VS. Effect
of glutamine on methotrexate efficacy and toxicity. Ann Surg 1998;
227:772-8.
47.
Wolff JE, Hauch H, Kuhl J, Egeler RM, Jurgens H. Dexamethasone increases
hepatotoxicity of MTX in children with brain tumors. Anticancer
Res 1998; 18:2895-9.
48.
Kepka L, De Lassence A, Ribrag V, Gachot B, Blot F, Theodore C,
Bonnay M, Korenbaum C, Nitenberg G. Successful rescue in a patient
with high dose methotrexate-induced nephrotoxicity and acute renal
failure. Leuk Lymphoma 1998; 29:205-9.
49.
Branda RF, Nigels E, Lafayette AR, Hacker M. Nutritional folate
status influences the efficacy and toxicity of chemotherapy in rats.
Blood 1998; 92:2471-6.
50.
Shiroky JB. The use of folates concomitantly with low-dose pulse
methotrexate. Rheum Dis Clin North Am 1997;23:969-80.
51.
Keshava C, Keshava N, Whong WZ, Nath J, Ong TM. Inhibition of methotrexate-induced
chromosomal damage by folinic acid in V79 cells. Mutat Res 1998;
397:221-8.
52.
Morgan SL and Baggott JE. Folate antagonists in nonneoplastic disease:
Proposed mechanisms of efficacy and toxicity. In: Bailey LB, ed.
Folate in Health and Disease. New York: Marcel Dekker, 1995: 405-433.
53.
Morgan SL BJ, Alarcon GS. Methotrexate in rheumatoid arthritis.
Folate supplementation should always be given. Bio Drugs 1997; 8:164-175.
54.
Morgan SL, Baggott JE, Lee JY, Alarcon GS. Folic acid supplementation
prevents deficient blood folate levels and hyperhomocysteinemia
during longterm, low dose methotrexate therapy for rheumatoid arthritis:
Implications for cardiovascular disease prevention. J Rheumatol
1998; 25:441-6.
55.
Hathcock JN. Vitamins and minerals: Efficacy and safety. Am J Clin
Nutr 1997;66:427-37. 56. Dietary Guidelines Advisory Committee,
Agricultural Research Service, United States Department of Agriculture
(USDA). Report of the Dietary Guidelines Advisory Committee on the
Dietary Guidelines for Americans, 2000. http://www.ars.usda.gov/dgac
|
